Enhanced Cas12a multi-gene regulation using a CRISPR array separator

  1. Jens P Magnusson
  2. Antonio Ray Rios
  3. Lingling Wu
  4. Lei Stanley Qi  Is a corresponding author
  1. Stanford University, United States

Abstract

The type V-A Cas12a protein can process its CRISPR array, a feature useful for multiplexed gene editing and regulation. However, CRISPR arrays often exhibit unpredictable performance due to interference between multiple guide RNA (gRNAs). Here, we report that Cas12a array performance is hypersensitive to the GC content of gRNA spacers, as high-GC spacers can impair activity of the downstream gRNA. We analyze naturally occurring CRISPR arrays and observe that natural repeats always contain an AT-rich fragment that separates gRNAs, which we term a CRISPR separator. Inspired by this observation, we design short, AT-rich synthetic separators (synSeparators) that successfully remove the disruptive effects between gRNAs. We further demonstrate enhanced simultaneous activation of seven endogenous genes in human cells using an array containing the synSeparator. These results elucidate a previously underexplored feature of natural CRISPR arrays and demonstrate how nature-inspired engineering solutions can improve multi-gene control in mammalian cells.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files. Source data have been provided for all figures.

Article and author information

Author details

  1. Jens P Magnusson

    Bioengineering Department, Stanford University, Stanford, United States
    Competing interests
    Jens P Magnusson, The authors have filed a US provisional patent application related to this work (application no. 63/139,095)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3928-8959
  2. Antonio Ray Rios

    Bioengineering Department, Stanford University, Stanford, United States
    Competing interests
    Antonio Ray Rios, The authors have filed a US provisional patent application related to this work (application no. 63/139,095)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6717-2267
  3. Lingling Wu

    Bioengineering Department, Stanford University, Stanford, United States
    Competing interests
    Lingling Wu, The authors have filed a US provisional patent application related to this work (application no. 63/139,095)..
  4. Lei Stanley Qi

    Bioengineering Department, Stanford University, Stanford, United States
    For correspondence
    stanley.qi@stanford.edu
    Competing interests
    Lei Stanley Qi, The authors have filed a US provisional patent application related to this work (application no. 63/139,095)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3965-3223

Funding

Li Ka Shing Foundation

  • Lei Stanley Qi

NIH Common Fund 4D Nucleome Program (U01 EB021240)

  • Lei Stanley Qi

Human Frontier Science Program (Long-term Fellowship)

  • Jens P Magnusson

Sweden-America Foundation

  • Jens P Magnusson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Joseph T Wade, Wadsworth Center, New York State Department of Health, United States

Publication history

  1. Received: January 9, 2021
  2. Preprint posted: January 27, 2021 (view preprint)
  3. Accepted: September 8, 2021
  4. Accepted Manuscript published: September 9, 2021 (version 1)
  5. Accepted Manuscript updated: September 13, 2021 (version 2)
  6. Version of Record published: September 28, 2021 (version 3)

Copyright

© 2021, Magnusson et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,984
    Page views
  • 317
    Downloads
  • 3
    Citations

Article citation count generated by polling the highest count across the following sources: PubMed Central, Crossref, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jens P Magnusson
  2. Antonio Ray Rios
  3. Lingling Wu
  4. Lei Stanley Qi
(2021)
Enhanced Cas12a multi-gene regulation using a CRISPR array separator
eLife 10:e66406.
https://doi.org/10.7554/eLife.66406

Further reading

    1. Chromosomes and Gene Expression
    2. Developmental Biology
    Lewis Macdonald et al.
    Tools and Resources

    Auxin-inducible degrons are a chemical genetic tool for targeted protein degradation and are widely used to study protein function in cultured mammalian cells. Here we develop CRISPR-engineered mouse lines that enable rapid and highly specific degradation of tagged endogenous proteins in vivo. Most but not all cell types are competent for degradation. By combining ligand titrations with genetic crosses to generate animals with different allelic combinations, we show that degradation kinetics depend upon the dose of the tagged protein, ligand, and the E3 ligase substrate receptor TIR1. Rapid degradation of condensin I and condensin II - two essential regulators of mitotic chromosome structure - revealed that both complexes are individually required for cell division in precursor lymphocytes, but not in their differentiated peripheral lymphocyte derivatives. This generalisable approach provides unprecedented temporal control over the dose of endogenous proteins in mouse models, with implications for studying essential biological pathways and modelling drug activity in mammalian tissues.

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Jakub Gemperle et al.
    Tools and Resources

    CRISPR technology has made generation of gene knock-outs widely achievable in cells. However, once inactivated, their re-activation remains difficult, especially in diploid cells. Here, we present DExCon (Doxycycline-mediated endogenous gene Expression Control), DExogron (DExCon combined with auxin-mediated targeted protein degradation), and LUXon (light responsive DExCon) approaches which combine one-step CRISPR-Cas9-mediated targeted knockin of fluorescent proteins with an advanced Tet-inducible TRE3GS promoter. These approaches combine blockade of active gene expression with the ability to re-activate expression on demand, including activation of silenced genes. Systematic control can be exerted using doxycycline or spatiotemporally by light, and we demonstrate functional knock-out/rescue in the closely related Rab11 family of vesicle trafficking regulators. Fluorescent protein knock-in results in bright signals compatible with low-light live microscopy from monoallelic modification, the potential to simultaneously image different alleles of the same gene, and bypasses the need to work with clones. Protein levels are easily tunable to correspond with endogenous expression through cell sorting (DExCon), timing of light illumination (LUXon), or by exposing cells to different levels of auxin (DExogron). Furthermore, our approach allowed us to quantify previously unforeseen differences in vesicle dynamics, transferrin receptor recycling, expression kinetics, and protein stability among highly similar endogenous Rab11 family members and their colocalization in triple knock-in ovarian cancer cell lines.